Issue #265
- Fewer AIDS Deaths and Illnesses: New Information
- Nelfinavir - Major Trial Results at Retroviruses Conference
- DANGER: Possibly Fatal Interactions Between Ritonavir and "Ecstasy," Some Other Psychoactive Drugs
- Free Viral Load Tests Becoming Available for Uninsured Patients
- ABT-378: Abbott "Second Generation" Protease Inhibitor
- Drug-Related Neuropathy: Low Acetylcarnitine Levels Found
- San Francisco: 9th National AIDS Update Conference, March 18-22
- New York: "Management of the HIV-Infected Patient," March 7-9
- New York: ACT UP 10-Year Anniversary -- Activist Conference Mar. 22-23, Wall Street Demo March 24
- Retroviruses Conference Information: Tape Sales; Email Access
- Medical Marijuana: New Nationwide Poll Shows 2-1 Public Support
- Medical Marijuana: Followup on THC Toxicology Report
source: AIDS Treatment News
